Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | Clinical and Translational Allergy

Figure 4

From: Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study

Figure 4

Daily mean Adjusted Symptom Score and birch pollen season. Data are presented for Periods 1 (A) and 2 (B) in the FASP1 and FASP2. The daily mean birch pollen count (grains/m3) was the average of pollen count weighted by the number of patients within the catchment area of each pollen trap.

Back to article page